Hormonal Contraception Market is forecast to increase from USD 21.46 Billion in 2025 to USD 35.63 Billion by 2036, at a projected CAGR of 5.2%. In terms of product, Oral Contraceptive Pills is expected to hold the largest share at 40.2%, while Combined Hormonal Contraceptive will account for a 58.7% share in the hormones segment.